RE: RE: Phase 2A lot of speculation it would appear is on the board today,and I myself probabally don't know a lot more than most.I do have my own thoughts about price as some have asked,let's just say that it is far north of where we are at.
I still don't necessarily believe that pfizer will be the pharma. There are a lot of big players out there and the longer that onc can wait,(or at least until towards the end of phase 2 for the prostate)the better it will be in the long run.
The reason for this is that they will definately have more concrete evidence in regards to efficacy,the glio will be filed and approved and so on.If this doesn't move the stock and provide onc with a better position I don't know what will.
The one caveat to this is that onc already know what the results will be as a result of the phase 1,and they and a pharma have all the info that they need to do a deal that is most likely very favorable to both. In this case trials will be ramped up so quickly that your head will spin and there will be no way that news will be suppressed as it would not be beneficial to anyone involved. And if money ever needed to be raised in this case it would be at a much higher price than we have today.
The glio trials once approved will happen very quickly as the timeline for life expectancy for these patients is generally one year at most. ONC will know right away as to the condition of these patients,and enrollment won't take long as to,where else can these people turn to.
I know that stock price is one thing,but I really hope that this could be a breakthrough for the millions of people that it will and ultimatly will affect.I have seen enough of the science to believe and just hope that the trials will help verify all of this.
Thanks as always for the time and input that you all provide.
Inthno